Cannabinoid hyperemesis syndrome (CHS) is recurrent nausea, vomiting, and abdominal pain due to prolonged cannabis use. This study aimed to differentiate the significant overlap in presentations of diabetic gastroparesis (DG) and CHS in people with type 1 diabetes. It found that older age, longer diabetes duration, female sex, lower A1C, and presence of diabetic neuropathy are indicators favoring a diagnosis of DG over CHS in people with type 1 diabetes.
This content is only available via PDF.
©2025 by the American Diabetes Association
2025
Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at https://www.diabetesjournals.org/journals/pages/license.
You do not currently have access to this content.
